:: Library Catalog

Buchumschlag

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	Badhe, Pravin
Format:	Recurso digital
Sprache:
Veröffentlicht:	Zenodo 2025
Online-Zugang:	https://doi.org/10.5281/zenodo.17896589
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Formulation Innovations Targeting ACTB Pathways in Breast Cancer: From Cytoskeletal Dysregulation to Precision Drug Delivery
von: Badhe, Ashwini
Veröffentlicht: (2025)

From Bench to Biomarkers: RNA-seq-Driven Discovery of Chemoprevention Biomarkers in Animal Models
von: Badhe, Ashwini, et al.
Veröffentlicht: (2026)

Clinical Relevance of EGFR in Breast Cancer: Precision Targeting for Better Outcomes
von: Badhe, Pravin
Veröffentlicht: (2025)

RNA-seq–Based Mechanistic Evaluation of Phytochemicals and Small Molecules in Experimental Cancer Models
von: Badhe, Pravin, et al.
Veröffentlicht: (2026)

In Vitro Validation of Herbal Products: Insights from MTT, ELISA, and Mechanistic Assays
von: Badhe, Pravin
Veröffentlicht: (2025)

Pharma Marketing Management
von: Dr. Krishnananda Kamath K, Dr. Pravin Badhe, Tapan Kumar Mahato and Ashwini Badhe
Veröffentlicht: (2025)

Long-Tail Knowledge in Large Language Models: Taxonomy, Mechanisms, Interventions and Implications
von: Badhe, Sanket, et al.
Veröffentlicht: (2026)

Glutathione‐Depletable Nanoinducer for Boosting Immunomodulatory Synergistic Therapy to Reverse Breast Cancer Chemoresistance
von: Senyi Gong, et al.
Veröffentlicht: (2025)

Repurposing Doxycycline to Overcome High‐Glucose–Induced Mitochondrial Biogenesis–Mediated Chemoresistance in Colorectal Cancer Cells
von: Chang‐Han Wu, et al.
Veröffentlicht: (2025)

LegalSim: Multi-Agent Simulation of Legal Systems for Discovering Procedural Exploits
von: Badhe, Sanket
Veröffentlicht: (2025)

ScamAgents: How AI Agents Can Simulate Human-Level Scam Calls
von: Badhe, Sanket
Veröffentlicht: (2025)

Understanding and Overcoming Antibody‐Drug Conjugate Resistance: Biological Mechanisms and Emerging Analytical Frameworks in Breast Cancer
von: Minji Seo, et al.
Veröffentlicht: (2026)

Discovery of Capsazepine as a Novel MCL1 Inhibitor for Overcoming Tamoxifen Resistance in Breast Cancer Therapy
von: Shujing Liu, et al.
Veröffentlicht: (2026)

Correction to “Terpenoids From Quinoa Reverse Chemoresistance in Breast Cancer by Suppressing the Stemness‐Related lncRNA 667012”
Veröffentlicht: (2025)

Permeable Lung Vasculature Creates Chemoresistant Endothelial Niche by Producing SERPINE1 at Breast Cancer Metastatic Sites
von: Tsunaki Hongu, et al.
Veröffentlicht: (2025)

Exosomes in the Chemoresistance of Glioma: Key Point in Chemoresistance
von: Xu Guo, et al.
Veröffentlicht: (2025)

Prompt-Level Distillation: A Non-Parametric Alternative to Model Fine-Tuning for Efficient Reasoning
von: Badhe, Sanket, et al.
Veröffentlicht: (2026)

Photodynamic Priming and Minocycline Overcome Chemoresistance by Reprogramming the Pancreatic Tumor Immune Microenvironment In Vivo
von: Fernanda V. Cabral, et al.
Veröffentlicht: (2026)

Evaluating the Diagnostic Potential of Biomarker Panels in Breast Cancer and Prostate Adenocarcinoma
von: Kldiashvili Ekaterina, et al.
Veröffentlicht: (2025)

OGT‐Mediated O‐GlcNAcylation Stabilizes c‐Myc Activity and Promotes Chemoresistance in Triple‐Negative Breast Cancer
von: Jie Li, et al.
Veröffentlicht: (2026)

A Novel “Three‐in‐One” Copper‐Based Metal‐Organic Framework Nanozyme Eradicates Colorectal Cancer and Overcomes Chemoresistance for Tumor Therapy
von: Shuohui Dong, et al.
Veröffentlicht: (2024)

Role Of Lipid Carriers in Overcoming Drug Resistance in Cancer
von: P. Sushma*, S. Varalaxmi
Veröffentlicht: (2025)

Fabrication of Redox‐Responsive Macromolecular Prodrug Nanoparticles and Studies on Their In Vitro Therapeutic Efficacy of Breast Cancer
von: Yuxin Wang, et al.
Veröffentlicht: (2025)

Targeting PKC as a Therapeutic Strategy to Overcome Chemoresistance in TNBC by Restoring Aurora Kinase B Expression
von: Bing Cheng, et al.
Veröffentlicht: (2025)

NGR‐Modified CAF‐Derived exos Targeting Tumor Vasculature to Induce Ferroptosis and Overcome Chemoresistance in Osteosarcoma
von: Jianxin Du, et al.
Veröffentlicht: (2025)

Chemoresistance and Immune Suppression in Gastric Cancer Are Driven by PPDPF Overexpression
von: Chenqiang Pan, et al.
Veröffentlicht: (2026)

Discordance Between Breast and Nodal Pathologic Response in Triple‐Negative Breast Cancer: Methodological Considerations and Contemporary Implications
von: Kadri Altundag
Veröffentlicht: (2026)

A Novel PCD‐Driven Risk Model Predicts Prognosis and Chemoresistance in Gastric Cancer Through Tumor Microenvironment Deregulation
von: Xueying Wu, et al.
Veröffentlicht: (2025)

Z‐Guggulsterone Induces Ferroptosis in Chemoresistant Breast Cancer via a CDKN2B ‐Mediated Suppression of GTP Cyclohydrolase 1
von: Zhuo‐Tao Yang, et al.
Veröffentlicht: (2026)

Mediastinal Teratoma With Somatic‐Type Adenocarcinoma: An Enigmatic Discovery by Fine Needle Aspiration Cytology
von: Swetha Venkatakrishnan, et al.
Veröffentlicht: (2025)

The Use of FN‐Silk Networks as Extracellular Matrix‐Mimicking Support for 3D In Vitro Breast Cancer Models Improved the Model's Reproducibility in Drug Sensitivity
von: Suha Karrani, et al.
Veröffentlicht: (2026)

Quantum AI for Cancer Diagnostic Biomarker Discovery
von: Saggi, Mandeep Kaur, et al.
Veröffentlicht: (2026)

Multi-modal Knowledge Decomposition based Online Distillation for Biomarker Prediction in Breast Cancer Histopathology
von: Zhang, Qibin, et al.
Veröffentlicht: (2025)

Transfer RNA‐Derived Small RNAs: Novel Predictive Biomarkers for Diagnosis and Prognosis of Breast Cancer
von: Lihan Bie, et al.
Veröffentlicht: (2026)

Phytochemical‐Based Drug Discovery for Breast Cancer: Combining Virtual Screening and Molecular Dynamics to Identify Novel Therapeutics
von: Trupti Pratik Durgawale, et al.
Veröffentlicht: (2025)

Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)
von: Andrew M. Riselli, et al.
Veröffentlicht: (2025)

Targeting ERα Coregulator Networks to Overcome Endocrine Resistance in ER + Breast Cancer
von: Monika Bar, et al.
Veröffentlicht: (2026)

A Novel “Three‐in‐One” Copper‐Based Metal‐Organic Framework Nanozyme Eradicates Colorectal Cancer and Overcomes Chemoresistance for Tumor Therapy (Adv. Sci. 6/2025)
von: Shuohui Dong, et al.
Veröffentlicht: (2025)

Nanoinjection Platform for Drug Delivery in Breast Cancer Therapeutics
von: Kaviya Vijayalakshmi Babunagappan, et al.
Veröffentlicht: (2025)

Reduction of Chemoresistance by Claudin‐14‐Targeting Peptide in Human Colorectal Cancer Cells
von: Yuko Mizukami, et al.
Veröffentlicht: (2024)